Study Reveals New Pathway for Brain Tumor Therapy
A new Yale Cancer Center study reports the nucleoside...
Novartis Receives FDA Breakthrough Therapy Designation for 177Lu-PSMA-617 in mCRPC Patients
The US Food and Drug Administration (FDA) has granted...
SNMMI ’21: PSMA-Targeted Radiotracer Pinpoints Metastatic Prostate Cancer
A phase III clinical trial has validated the...
